The company is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of securities by the selling securityholders. Published first on
The company is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of securities by the selling securityholders. Published first on
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Verrica Pharmaceuticals (VRCA), 658% surge in interest Macrogenics (MGNX),
Emergent BioSolutions (EBS) is up 31.2%, or $2.87 to $12.07. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks
Emergent BioSolutions (EBS) עולים ב-31.2%, או $2.87, ומגיעים ל-$12.07.
Get caught up quickly on the top news and calls moving stocks with these